Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations

BACKGROUND: Endocrine FGF21 and FGF19 target adipocytes and hepatocytes through betaKlotho (KLB) and FGFR tyrosine kinases effecting glucose, lipid and energy metabolism. Both factors alleviate obesity and metabolic abnormalities which are contributing factors to breast tumor progression. Genomic ma...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Luo, Yongde, Yang, Chaofeng, Ye, Min, Jin, Chengliu, Abbruzzese, James L, Lee, Mong-Hong, Yeung, Sai-Ching J, McKeehan, Wallace L
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178208/
https://ncbi.nlm.nih.gov/pubmed/24279986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2049-3002-1-21
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars